Point-of-Care Diagnostics Devices And Equipment Market Research Reveals Path To $118.72 Billion By 2030

The market for point-of-care diagnostics devices and equipment is poised for significant advancement in the coming years. As healthcare moves towards more accessible and immediate testing solutions, the demand for efficient, user-friendly diagnostic tools is accelerating. This overview explores the market size, key players, emerging trends, and the segmentation of this rapidly evolving sector.

Forecasted Market Size and Growth Trajectory of Point-of-Care Diagnostics Devices and Equipment
The point-of-care diagnostics devices and equipment market is set to experience rapid expansion, reaching a market value of $118.72 billion by 2030. This represents a strong compound annual growth rate (CAGR) of 13.5%. The surge in market size is largely driven by the increasing popularity of home healthcare diagnostics, the integration of digital health ecosystems, expanded infectious disease screening initiatives, and greater adoption of AI-supported diagnostic tools. Additionally, an emphasis on remote patient monitoring is playing a crucial role in propelling growth. Key trends anticipated to shape the market include the growing use of rapid diagnostic tests, the rise of decentralized healthcare diagnostics, enhanced connectivity of point-of-care platforms, expansion of home testing solutions, and a focused push toward designing more user-friendly devices.

Download a free sample of the Point-of-Care Diagnostics Devices And Equipment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2387&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Primary Companies Leading the Point-of-Care Diagnostics Devices and Equipment Market
The competitive landscape of the point-of-care diagnostics devices and equipment market features several prominent companies, including Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers, Danaher, Beckman Coulter, Becton dic*kinson and Company, Qiagen N.V., Johnson & Johnson, Alere, BioMerieux, Chembio Diagnostic Systems, Quidel Corporation, EKF Diagnostics, Trinity Biotech Plc, OraSure Technologies, Sysmex Corporation, Radiometer Medical ApS, Response Biomedical Corporation, Bio-Rad Laboratories, Illumina, Thermo Fisher Scientific Inc., LabCorp, Luminex Corporation, LifeScan, Nova, Sekisui Diagnostics, Hemocue AB, and Akers Biosciences.

Strategic Acquisition Enhances Roche's Point-of-Care Testing Portfolio
In December 2023, Roche, a Switzerland-based healthcare company specializing in pharmaceuticals, in vitro diagnostics, and healthcare solutions, acquired select point-of-care technology assets from UK-based LumiraDx for US$ 295 million. This acquisition is aimed at integrating a versatile multi-assay point-of-care platform into Roche's diagnostics portfolio, enhancing its capabilities for decentralized testing, especially in primary care and low-resource environments. LumiraDx is recognized for its innovative point-of-care diagnostic solutions.

View the full Point-of-Care Diagnostics Devices And Equipment market report:
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Innovations Shaping the Future of Point-of-Care Diagnostics Devices and Equipment
Leading companies in the point-of-care diagnostics devices and equipment market are focusing on innovative products designed to improve healthcare accessibility and speed up diagnosis. A notable example is Cippoint, a multifunctional point-of-care testing device. Launched by India-based pharmaceutical company Cipla Limited in January 2023, Cippoint provides a broad array of testing parameters such as cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. This immunofluorescence-based quantitative analyzer delivers results within 3 to 15 minutes, enabling healthcare professionals to make timely clinical decisions. Its user-friendly design allows for use in diverse settings like hospitals, clinics, and mobile healthcare units.

Detailed Segmentation of the Global Point-of-Care Diagnostics Devices and Equipment Market
This market is segmented in several ways, providing a clear picture of product diversity and end-user applications.
1) By Type: Infectious disease testing kits, cardio metabolic monitoring kits, cholesterol testing kits, pregnancy and fertility test kits, tumor or cancer markers, urinalysis testing kits, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, and other types.
2) By Prescription Mode: Prescription-based testing devices and over-the-counter (OTC) testing devices.
3) By End User: Professional diagnostic centers, hospitals/critical care centers, outpatient healthcare settings, ambulatory care settings, research laboratories, and home use.

Subcategories are further specified within each type. For infectious disease testing kits, examples include HIV, hepatitis, malaria, influenza, COVID-19, and other infectious disease kits. Cardio metabolic monitoring includes blood glucose, blood pressure, lipid testing, and others. Cholesterol tests cover total cholesterol, HDL, LDL, and triglycerides. Pregnancy and fertility kits involve pregnancy tests, ovulation tests, and fertility monitoring. Tumor or cancer marker kits include PSA, HER2, CA-125, AFP, and other cancer markers. Urinalysis kits encompass protein, glucose, pH, specific gravity, nitrite, and other tests. Hematology kits consist of complete blood count (CBC), hemoglobin, hematocrit, platelet count, and other hematology tests. Drugs of abuse kits cover marijuana, cocaine*, opioids, amphetamines, and others. Fecal occult testing kits include stool blood and occult blood screening tests. Other types cover glucose monitoring, temperature monitoring, oxygen saturation monitoring, and additional specialty point-of-care kits.

Regional Distribution and Market Outlook
As of 2024, North America holds the largest share of the point-of-care diagnostics devices and equipment market. Nevertheless, the Asia-Pacific region is expected to witness the fastest growth in the foreseeable future. The market study encompasses key geographical areas including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa, offering a thorough global perspective on market trends and opportunities.

Expanded capabilities in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.